Annuncio • May 30
China Bluechemical Ltd. Approves Annual Final Dividends for the Year Ended 31 December 2025, Payable on on or About 30 June 2026 China BlueChemical Ltd. announced that the proposed annual final dividends of RMB 0.112 per Share (tax inclusive) for the year ended 31 December 2025 have been approved by the Shareholders at the AGM. The final dividends for H Shareholders will be paid in Hong Kong dollars, with the Hong Kong dollar to Renminbi exchange rate being the average mid-point rate published by the People's Bank of China on the website for the period of seven working days immediately prior to the date of the declaration of dividends. The applicable exchange rate for the purpose of the payment of the final dividends is therefore HKD 1.00 = RMB 0.87238. Accordingly, the final dividends of HKD 0.1284 per H Share (tax inclusive) of the Company are expected to be paid on or about 30 June 2026 and will be paid on a day which is not a Saturday, Sunday or public holiday in Hong Kong to Shareholders whose names appear on the registers of members of the Company on 8 June 2026. Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Wanhong Yang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Apr 13
China BlueChemical Ltd., Annual General Meeting, May 28, 2026 China BlueChemical Ltd., Annual General Meeting, May 28, 2026, at 09:00 China Standard Time. Location: 3rd floor meeting room, yihai international, haikou China Annuncio • Mar 03
China BlueChemical Ltd. to Report Fiscal Year 2025 Results on Mar 17, 2026 China BlueChemical Ltd. announced that they will report fiscal year 2025 results on Mar 17, 2026 Annuncio • Aug 04
China BlueChemical Ltd. to Report First Half, 2025 Results on Aug 18, 2025 China BlueChemical Ltd. announced that they will report first half, 2025 results on Aug 18, 2025 Annuncio • Apr 11
China BlueChemical Ltd., Annual General Meeting, May 29, 2025 China BlueChemical Ltd., Annual General Meeting, May 29, 2025. Annuncio • Mar 18
China Bluechemical Ltd. Proposes Final Dividend for the Year Ended December 31, 2024, Payable on 30 June 2025 China BlueChemical Ltd. proposed final dividend of RMB 0.1208 per share for the year ended December 31, 2024. Payment date is 30 June 2025. Annuncio • Mar 03
China BlueChemical Ltd. to Report Fiscal Year 2024 Results on Mar 18, 2025 China BlueChemical Ltd. announced that they will report fiscal year 2024 results on Mar 18, 2025 Annuncio • Oct 31
China BlueChemical Ltd. Announces Board Changes China BlueChemical Ltd. announced that Mr. Hou Xiaofeng, the executive Director performing the duties and responsibilities of the chairman of the Board and the chairman of the nomination committee of the Board, was appointed as the Chairman as well as the chairman of the Nomination Committee with effect from 30 October 2024. Mr. Hou will only receive remuneration for his position as senior management of the Company but will not receive director's remuneration during his term as the executive Director and Chairman. The Board announced that Mr. Li Ruiqing has resigned from his position as an executive Director due to other work arrangements. His resignation took effect upon 30 October 2024. Reported Earnings • Sep 24
First half 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.37 in 1H 2023) First half 2024 results: EPS: CN¥0.15 (down from CN¥0.37 in 1H 2023). Revenue: CN¥6.01b (down 2.7% from 1H 2023). Net income: CN¥686.8m (down 60% from 1H 2023). Profit margin: 11% (down from 28% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 23
First half 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.37 in 1H 2023) First half 2024 results: EPS: CN¥0.15 (down from CN¥0.37 in 1H 2023). Revenue: CN¥6.01b (down 2.7% from 1H 2023). Net income: CN¥686.8m (down 60% from 1H 2023). Profit margin: 11% (down from 28% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. New Risk • Aug 21
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 19% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (119% cash payout ratio). Share price has been volatile over the past 3 months (9.7% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin). Annuncio • Aug 05
China BlueChemical Ltd. to Report First Half, 2024 Results on Aug 19, 2024 China BlueChemical Ltd. announced that they will report first half, 2024 results on Aug 19, 2024 Buy Or Sell Opportunity • Jul 22
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 20% to €0.23. The fair value is estimated to be €0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.4% over the last 3 years. Earnings per share has grown by 27%. New Risk • Jun 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risks Dividend is not well covered by cash flows (119% cash payout ratio). Share price has been volatile over the past 3 months (7.4% average weekly change). Upcoming Dividend • May 28
Upcoming dividend of CN¥0.21 per share Eligible shareholders must have bought the stock before 04 June 2024. Payment date: 30 June 2024. Payout ratio is a comfortable 40% but the company is paying out more than the cash it is generating. Trailing yield: 8.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.1%). Reported Earnings • Apr 29
Full year 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.36 in FY 2022) Full year 2023 results: EPS: CN¥0.52 (up from CN¥0.36 in FY 2022). Revenue: CN¥13.0b (down 9.0% from FY 2022). Net income: CN¥2.38b (up 45% from FY 2022). Profit margin: 18% (up from 12% in FY 2022). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Annuncio • Apr 13
China BlueChemical Ltd., Annual General Meeting, May 28, 2024 China BlueChemical Ltd., Annual General Meeting, May 28, 2024, at 09:00 China Standard Time. Location: Meeting Room 1401, Kaikang CNOOC Mansion No. 15 Sanqu, Anzhenxili, Chaoyang Distric Beijing Province China Agenda: To consider and approve the report of the board of directors of the Company for the year ended 31 December 2023; to consider and approve the report of the supervisory committee of the Company for the year ended 31 December 2023; to consider and approve the audited financial statements and the auditors' report of the Company for the year ended 31 December 2023; to consider and approve the proposal for distribution of profit of the Company for the year ended 31 December 2023 and the declaration of the Company's final dividends; and to consider other business matters. Declared Dividend • Mar 27
Dividend of CN¥0.21 announced Shareholders will receive a dividend of CN¥0.21. Ex-date: 4th June 2024 Payment date: 30th June 2024 Dividend yield will be 82%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not covered by cash flows (160% cash payout ratio). The dividend has increased by an average of 3.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 32% over the next 2 years. However, it would need to fall by 55% to increase the payout ratio to a potentially unsustainable range. Reported Earnings • Mar 25
Full year 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.36 in FY 2022) Full year 2023 results: EPS: CN¥0.52 (up from CN¥0.36 in FY 2022). Revenue: CN¥13.0b (down 9.0% from FY 2022). Net income: CN¥2.38b (up 45% from FY 2022). Profit margin: 18% (up from 12% in FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • Mar 19
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 26% to €0.26. The fair value is estimated to be €0.22, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 35%. Annuncio • Mar 09
China BlueChemical Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024 China BlueChemical Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024 Buy Or Sell Opportunity • Feb 29
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 34% to €0.27. The fair value is estimated to be €0.22, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 35%. Buy Or Sell Opportunity • Jan 26
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 14% to €0.24. The fair value is estimated to be €0.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 35%. Board Change • Jan 02
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 3 experienced directors. 2 highly experienced directors. 3 independent directors (4 non-independent directors). Employee Representative Supervisor & GM of the Audit Department Lijie Liu is the most experienced director on the board, commencing their role in 2012. Independent Non-Executive Director Feng Lin was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Annuncio • Dec 22
China BlueChemical Ltd. Announces Board and Committee Changes China BlueChemical Ltd. announced that at its EGM held on December 22, 2023, approved the appointment of Ms. Shao Lihua as a non-executive Director; approved the appointment of Mr. Yang Dongzhao as a non-executive Director; approved the appointment of Mr. Zhang Bing as a Supervisor representing the Shareholders, to authorise Mr. Hou Xiaofeng, the executive Director, to sign the relevant service contract on behalf of the Company with Mr. Zhang Bing. At the meeting of the Board held on December 22, 2023, Ms. Shao has been appointed as a member of audit committee of the Board, a member of remuneration committee of the Board and a member of investment review committee of the Board and Mr. Yang has been appointed as a member of audit committee of the Board and a member of investment review committee of the Board. The resignation of Mr. Huang Hulong and Mr. Zhao Baoshun from non-executive Directors has been immediately effective upon approval of the appointment of Ms. Shao and Mr. Yang as non-executive Directors by Shareholders at the EGM. Reported Earnings • Aug 22
First half 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.20 in 1H 2022) First half 2023 results: EPS: CN¥0.37 (up from CN¥0.20 in 1H 2022). Revenue: CN¥6.18b (down 16% from 1H 2022). Net income: CN¥1.72b (up 83% from 1H 2022). Profit margin: 28% (up from 13% in 1H 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Annuncio • Aug 05
China BlueChemical Ltd. to Report First Half, 2023 Results on Aug 19, 2023 China BlueChemical Ltd. announced that they will report first half, 2023 results on Aug 19, 2023 Annuncio • Jul 27
China Bluechemical Ltd. Provides Earnings Forecast for the Six Months Ended 30 June 2023 China BlueChemical Ltd. provided earnings forecast for the six months ended 30 June 2023. For the period, the company expects the Group to record a netprofit attributable to owners of the Company under International Financial Reporting Standards approximately from RMB 1,700 million to RMB 1,730 million for the six months ended 30 June 2023, as compared to the net profit attributable to owners of the Company of approximately RMB 937 million for the six months ended 30 June 2022. New Risk • Jul 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10.0% average weekly change). Minor Risk Dividend is not well covered by cash flows (103% cash payout ratio). Annuncio • May 27
China BlueChemical Ltd. Appoints Li Ruiqing as an Executive Director China BlueChemical Ltd. at the AGM, the shareholders approved the appointment of Mr. Li Ruiqing as an Executive Director, to authorise the Executive Director to sign the relevant service contract on behalf of the Company with Mr. Li Ruiqing, and to authorise the Board, which in turn will further delegate the remuneration committee of the Board to determine his remuneration. Mr. Li will only receive remuneration for his position as senior management of the Company but will not receive director's remuneration during his term as the executive Director. As of the date of this announcement and save as disclosed in the Circular, Mr. Li did not hold any other directorships in other listed companies in the past three years and he (i) had no relationship with any Directors, supervisors, senior management or substantial or controlling Shareholders of the Company; (ii) had no interest in any Shares within the meaning of Part XV of the SFO; and (iii) held no other position with the Company or other members of the Group. Upcoming Dividend • May 23
Upcoming dividend of CN¥0.18 per share at 9.7% yield Eligible shareholders must have bought the stock before 30 May 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 50% and the cash payout ratio is 89%. Trailing yield: 9.7%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (5.6%). Reported Earnings • Mar 30
Full year 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.33 in FY 2021) Full year 2022 results: EPS: CN¥0.36 (up from CN¥0.33 in FY 2021). Revenue: CN¥14.3b (up 6.6% from FY 2021). Net income: CN¥1.64b (up 9.7% from FY 2021). Profit margin: 12% (in line with FY 2021). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Annuncio • Jan 06
China BlueChemical Ltd. Announces Change of Company Secretary and Change of Authorised Representative The board of directors of China BlueChemical Ltd. announced that Ms. Wu Xiaoxia has resigned as the company secretary of the Company due to other work commitment with effect from 5 January 2023. The Board is announced that Mr. Kuang Xiaobing and Ms. Ng Sau Mei have been appointed as the joint company secretaries of the Company with effect from 5 January 2023. The biographical details of Mr. Kuang and Ms. Ng are set out below. Mr. Kuang, born in 1967, obtained a master's degree from Beijing Business College (currently known as the Beijing Technology and Business University) in 1997, majoring in enterprise management. He was qualified as a senior economist. From September 1986 to August 1991, he studied in the department of engineering physics of Tsinghua University, majoring in nuclear and thermal energy utilization. From August 1991 to September 1994, Mr. Kuang served as an assistant engineer at the No. 2 Institute of Nuclear Industrial Research and Design. From September 1994 to June 1997, he studied at Beijing Business College, majoring in enterprise management, and obtained a master's degree. From June 1997 to May 1998, he worked as an economist in the financial department of China National Offshore Oil Corporation. From May 1998 to December 2000, he served as financial economist of Nanhai petrochemical project team of CNOOC. From December 2000 to August 2005, he served as the financing director of the finance department of CNOOC and Shell Petrochemical Company Limited. From August 2005 to December 2011, he successively served as the director of corporate financial analysis and management, the senior director of investment and financing and debt risk management, and the head of financing and capital market division of the capital financing department of CNOOC China Limited. From December 2011 to October 2016, he successively served as the head of the financing division, the head of the limited financing and capital market division, and the deputy head of the financing division of the capital department of CNOOC. Since October 2016, he has served as the deputy general manager of the capital department of CNOOC and CNOOC Limited. In November 2022, Mr. Kuang was appointed as the Company's vice president, chief financial officer, chief legal adviser and chief compliance officer. Ms. Ng, born in 1977, graduated with a bachelor's degree from City University of Hong Kong in 2001 majoring in laws and obtained a master's degree in laws from University of London in the United Kingdom in 2017. She became an associate member of The Hong Kong Chartered Governance Institute and The Chartered Governance Institute (formerly known as The Institute of Chartered Secretaries and Administrators) in the United Kingdom in 2007 and a fellow member in 2019. She is a director of the Listing Services Department of TMF Hong Kong Limited and is responsible for provision of corporate secretarial and compliance services to listed company clients. She currently serves as the joint company secretary for various companies listed on the Main Board of the Stock Exchange, including China Reinsurance (Group) Corporation (stock code: 1508), The People's Insurance Company (Group) of China Limited (stock code: 1339) and China Oilfield Services Limited (stock code: 2883). Following her resignation, Ms. Wu ceased to be the authorised representative of the Company for the purpose of Rule 3.05 of the Listing Rules and Mr. Kuang has been appointed as the Authorised Representative with effect from 5 January 2023. Board Change • Nov 16
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 7 new directors. 2 experienced directors. 1 highly experienced director. 3 independent directors (4 non-independent directors). Employee Representative Supervisor Lijie Liu is the most experienced director on the board, commencing their role in 2012. Independent Non-Executive Director Feng Lin was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 27
First half 2022 earnings released: EPS: CN¥0 (vs CN¥0.27 in 1H 2021) First half 2022 results: EPS: CN¥0 (down from CN¥0.27 in 1H 2021). Revenue: CN¥7.37b (up 21% from 1H 2021). Net income: CN¥937.0m (down 25% from 1H 2021). Profit margin: 13% (down from 20% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.8%, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Annuncio • Aug 16
China BlueChemical Ltd. to Report First Half, 2022 Results on Aug 25, 2022 China BlueChemical Ltd. announced that they will report first half, 2022 results on Aug 25, 2022 Annuncio • Jul 26
China Bluechemical Ltd. Provides Earning Guidance for the Six Months Ended 30 June 2022 China BlueChemical Ltd. provided earning guidance for the six months ended 30 June 2022. The board of directors of the Company informed its shareholders and potential investors that, based on information currently available, the Board expects the Group to record a net profit attributable to owners of the Company approximately from RMB923 million to RMB 953 million for the six months ended 30 June 2022 as compared to the net profit attributable to owners of the Company of approximately RMB1,246 million for the six months ended 30 June 2021. For the six months ended 30 June 2021, the net profit attributable to owners of the Company includes the gains from the disposal of the equity interests and the creditor's right in CNOOC Hualu Shanxi Coal Chemical Co. Ltd. and the equity interests in Shanxi Hualu Yangpoquan Coal Mining Co. Ltd. (the ``Disposal'') of RMB378 million, which led to the expected year-on-year decrease in the net profit attributable to owners of the Company for the six months ended 30 June 2022. Excluding the effect of the Disposal, the net profit attributable to owners of the Company for the six months ended 30 June 2022 is expected to increase year-on-year, which was primarily attributable to the increase in the prices of the Company's main products, such as urea, methanol, and phosphate fertilizes and compound fertilizers. Annuncio • May 28
China BlueChemical Ltd. Announces Final Cash Dividend for the Financial Year Ended 31 December 2021, Payable on 30 June 2022 China BlueChemical Ltd. announced final cash dividend of RMB 0.155 per share for the financial year ended 31 December 2021. With the ex-dividend date of 01 June 2022, record date of 08 June 2022 and payment date of 30 June 2022. Upcoming Dividend • May 25
Upcoming dividend of CN¥0.15 per share Eligible shareholders must have bought the stock before 01 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 6.8%. Within top quartile of German dividend payers (4.3%). Higher than average of industry peers (5.2%). Reported Earnings • May 02
Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.16 in FY 2020) Full year 2021 results: EPS: CN¥0.33 (up from CN¥0.16 in FY 2020). Revenue: CN¥13.4b (up 29% from FY 2020). Net income: CN¥1.50b (up 101% from FY 2020). Profit margin: 11% (up from 7.2% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 12%, compared to a 8.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 7 new directors. 2 experienced directors. 1 highly experienced director. 3 independent directors (4 non-independent directors). Employee Representative Supervisor Lijie Liu is the most experienced director on the board, commencing their role in 2012. Independent Non-Executive Director Feng Lin was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Annuncio • Apr 13
China BlueChemical Ltd., Annual General Meeting, May 27, 2022 China BlueChemical Ltd., Annual General Meeting, May 27, 2022, at 09:50 China Standard Time. Location: Meeting Room, 3rd Floor, Kaikang CNOOC Mansion, No. 15, Sanqu, Anzhenxili, Chaoyang District Beijing China Agenda: To consider and approve the report of the board of directors of the Company (the``Board'') for the year ended 31 December 2021; to consider and approve the report of the supervisory committee of the Company for the year ended 31 December 2021; and to consider and approve the amendments to Articles 17, 96, 97 and 102 of the Articles of Association and to authorize the Board to deal with on behalf of the Company the relevant filing and amendments (where necessary) procedures and other related issues arising from the amendments to the Articles of Association. Reported Earnings • Apr 01
Full year 2021 earnings released Full year 2021 results: Revenue: CN¥13.4b (up 29% from FY 2020). Net income: CN¥1.50b (up 101% from FY 2020). Profit margin: 11% (up from 7.2% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 12%, compared to a 7.6% growth forecast for the industry in Germany. Annuncio • Feb 12
China BlueChemical Ltd. Provides Earnings Guidance for the Year Ended 31 December 2021 China BlueChemical Ltd. provided earnings guidance for the year ended 31 December 2021. The board of directors expects the Group to record a net profit attributable to owners of the Company approximately from RMB 1,414 million to RMB 1,454 million for the year ended 31 December 2021 as compared to a net profit attributable to owners of the Company of approximately RMB 745 million for the year ended 31 December 2020. Board Change • Dec 25
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 7 new directors. 3 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Employee Representative Supervisor Lijie Liu is the most experienced director on the board, commencing their role in 2012. Independent Non-Executive Director Feng Lin was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 01
First half 2021 earnings released: EPS CN¥0.27 (vs CN¥0.067 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥6.11b (up 23% from 1H 2020). Net income: CN¥1.25b (up 302% from 1H 2020). Profit margin: 20% (up from 6.2% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 31
First half 2021 earnings released: EPS CN¥0.27 (vs CN¥0.067 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥6.11b (up 23% from 1H 2020). Net income: CN¥1.25b (up 302% from 1H 2020). Profit margin: 20% (up from 6.2% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Annuncio • Jul 24
China Bluechemical Ltd. Announces Earnings Guidance for the Six Months Ended 30 June 2021 China BlueChemical Ltd. announced that the board expects the Group to record a net profit attributable to owners of the Company approximately from RMB 1,230 million to RMB 1,260 million for the six months ended 30 June 2021. Executive Departure • Jun 04
Independent Non-Executive Director Kit Ying Lee has left the company On the 27th of May, Kit Ying Lee's tenure as Independent Non-Executive Director ended after 9.0 years in the role. We don't have any record of a personal shareholding under Kit Ying's name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is 2.63 years. Executive Departure • Jun 04
Independent Non-Executive Director Kwan Hung Lee has left the company On the 27th of May, Kwan Hung Lee's tenure as Independent Non-Executive Director ended after 9.0 years in the role. We don't have any record of a personal shareholding under Kwan Hung's name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is 2.63 years. Annuncio • May 28
China BlueChemical Ltd. Approves Final Dividend for the Year Ended 31 December 2020, Payable on or About June 30, 2021 China BlueChemical Ltd. approved the annual final dividends of RMB 0.08 per share (tax inclusive) for the year ended 31 December 2020 in the annual general meeting held on May 27, 2021. In accordance with Article 171 of the articles of association of the Company, the final dividends for H Shareholders will be paid in Hong Kong dollars, with the Hong Kong dollar to Renminbi exchange rate being the average mid-point rate published by the People's Bank of China on the website for the period of seven working days immediately prior to the date of the declaration of dividends. The applicable exchange rate for the purpose of the payment of the final dividends is therefore HKD 1.00 = RMB 0.82827. Accordingly, the final dividends of HKD 0.0966 per H Share (tax inclusive) of the Company are expected to be paid on or about 30 June 2021 and will be paid on a day which is not a Saturday, Sunday or public holiday in Hong Kong to Shareholders whose names appear on the registers of members of the Company on 8 June 2021. The Company will comply with the tax withholding obligations under the relevant PRC tax laws and regulations. Upcoming Dividend • May 25
Upcoming dividend of CN¥0.08 per share Eligible shareholders must have bought the stock before 01 June 2021. Payment date: 30 June 2021. Trailing yield: 3.9%. Within top quartile of German dividend payers (3.2%). In line with average of industry peers (3.6%). Reported Earnings • May 03
Full year 2020 earnings released: EPS CN¥0.16 (vs CN¥0.15 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥10.4b (down 4.1% from FY 2019). Net income: CN¥745.5m (up 6.0% from FY 2019). Profit margin: 7.2% (up from 6.5% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 27
Full year 2020 earnings released The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥10.4b (down 4.1% from FY 2019). Net income: CN¥745.5m (up 6.0% from FY 2019). Profit margin: 7.2% (up from 6.5% in FY 2019). The increase in margin was driven by lower expenses. Annuncio • Mar 16
China BlueChemical Ltd. to Report Fiscal Year 2020 Results on Mar 25, 2021 China BlueChemical Ltd. announced that they will report fiscal year 2020 results on Mar 25, 2021 Is New 90 Day High Low • Mar 01
New 90-day high: €0.23 The company is up 60% from its price of €0.14 on 01 December 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €0.19 per share. Is New 90 Day High Low • Feb 20
New 90-day high: €0.21 The company is up 44% from its price of €0.14 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €0.17 per share. Is New 90 Day High Low • Feb 10
New 90-day high: €0.20 The company is up 65% from its price of €0.12 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €0.14 per share. Reported Earnings • Oct 01
First half earnings released Over the last 12 months the company has reported total profits of CN¥464.4m, down 60% from the prior year. Total revenue was CN¥10.6b over the last 12 months, down 4.2% from the prior year. Annuncio • Aug 31
China BlueChemical Ltd. to Report First Half, 2020 Results on Aug 26, 2020 China BlueChemical Ltd. announced that they will report first half, 2020 results on Aug 26, 2020 Annuncio • Aug 13
China BlueChemical Ltd. Appoints Mr. Hou Xiaofeng as CEO The Board of China BlueChemical Ltd. announced that Mr. Hou Xiaofeng was appointed as the CEO, with effect from 12 August 2020. His term of office will last till the date of re-appointment of a new CEO and President by the next session of the Board. Subject to the approval of his appointment as an executive Director by the Shareholders. Mr. Hou Xiaofeng will enter into a service contract with the Company. Hou From September 2001 to March 2015, he served successively as the information technology director, chief technology officer and chief engineer of CNOOC's information management department, and during this period, he worked concurrently as a member of CNOOC's ERP project preparation team and manager of the technology team from June 2004 to November 2009. From March 2015 to March 2018, he held the positions of chief engineer of information department of CNOOC and that of CNOOC Limited. Annuncio • Jun 19
Hequ Taiyang Coal Industry Co., Ltd. agreed to acquire 51% stake in CNOOC Hualu Shanxi Coal Chemical Co., Ltd. from China BlueChemical Ltd. (SEHK:3983). Hequ Taiyang Coal Industry Co., Ltd. agreed to acquire 51% stake in CNOOC Hualu Shanxi Coal Chemical Co., Ltd. from China BlueChemical Ltd. (SEHK:3983) on May 10, 2020. Hequ Taiyang Coal Industry Co., Ltd. entered into equity transaction agreement to acquire 51% stake in CNOOC Hualu Shanxi Coal Chemical Co., Ltd from China BlueChemical Ltd. (SEHK:3983) for approximately CNY 100 million on June 18, 2020. CNY 40.59 million is the price for the 51% equity interests in CNOOC Hualu Shanxi Coal Chemical and CNY 61.48 million will be paid for the creditors' rights in target held by China BlueChemical. Hequ Taiyang Coal Industry will pay the final consideration in lump-sum in cash. In a related transaction, Hequ Taiyang Coal Industry Co., Ltd. agreed to acquire 49% stake in Shanxi Hualu Yangpoquan Coal Mining Co., Ltd from China BlueChemical Ltd. The combined transaction value is approximately CNY 740 million. Hequ Taiyang Coal Industry Co., Ltd. has in a timely manner, paid the 30% of the Base price of the combined consideration. Upon completion of the potential disposal, CNOOC Hualu Shanxi Coal Chemical Co., Ltd. will cease to be a subsidiary of China BlueChemical Ltd. When either party terminates the contract without proper reason, it shall make the one-off payment of liquidated damages to the counterparty at 30% of the final combined consideration as stipulated in the Equity Transaction Agreements. China BlueChemical Ltd. intends to use the proceeds from the Potential Disposal for daily manufacture and operation. 
